• Notice
000 nam 22 3 450
001 FRBNF446422870000004
010 .. $a 9780387329567
035 .. $a OCoLC166391727
100 .. $a 20170801d2006 m y0engy50 ba
101 0. $a eng
102 .. $a US
105 .. $a a z 00|y|
106 .. $a s $a z
135 .. $a dru||||||||||
181 .0 $6 01 $a i $b xxxe
181 .. $6 02 $c txt $2 rdacontent
182 .0 $6 01 $a b
182 .. $6 02 $c c $2 rdamedia
200 1. $a Peptide nucleic acids, morpholinos and related antisense biomolecules $b Texte électronique $f [edited by] Christopher G. Janson, Matthew J. During
210 .. $a Georgetown, Tex. $c Landes Bioscience/Eurekah.com $a New York, N.Y. $c Kluwer Academic/Plenum Publishers $d cop. 2006
215 .. $a 1 online resource (274 pages)
225 1. $a Medical intelligence unit
300 .. $a Includes bibliographical references and index
330 .. $a This volume is unique to the existing literature in the Peptide Nucleic Acid field, in that it focuses on comparing and contrasting PNA with other available oligonucleotide homologues and considers areas in which these biomolecules could be profitably applied to clinical and diagnostic applications. Part I of the book addresses comparative strengths and weaknesses of various nucleoside homologues. Part II of the book addresses specific translational or clinical applications for PNA and related antisense biomolecules. The editors have succeeded in presenting a balanced yet broad view of the methods available for gene targeting and modification
606 .. $3 12348516 $a Acides nucléiques antisens $2 rameau
606 .. $3 12348544 $a Peptides antisens $2 rameau
606 .. $3 11971633 $a Sciences de la vie $2 rameau
676 .. $a 612.015 756 $v 23
702 .| $3 17234095 $a Janson $b Christopher G. $4 570
702 .| $3 17211925 $a During $b Matthew J. $4 570
801 .3 $a US $b OCoLC $c 20170801 $h 166391727 $2 marc21
801 .0 $b COO $g pn
930 .. $5 FR-759999999:44642287001001 $a ACQNUM-24053 $b 759999999 $c Document numérisé $d N

Localiser ce document(1 Exemplaire)

Document numérique : 

1 partie d'exemplaire regroupée

ACQNUM-24053
support : document électronique dématérialisé